MAKI Toshio | Pharmaceutical Regulatory Affairs and Quality Assurance Department, Pharmaceutical Company, Ajinomot

スポンサーリンク

概要

関連著者

Yasuda Masaharu
Pharmacovigilance Department Mochida Pharmaceutical Co. Ltd.
NAGAHAMA Shinobu
Pharmaceutical Regulatory Affairs and Quality Assurance Department, Pharmaceutical Company, Ajinomot
NORIMATSU Takeo
Pharmaceutical Regulatory Affairs and Quality Assurance Department, Pharmaceutical Company, Ajinomot
MAKI Toshio
Pharmaceutical Regulatory Affairs and Quality Assurance Department, Pharmaceutical Company, Ajinomot
TANAKA Shinsuke
Pharmacovigilance Department, Mochida Pharmaceutical Co., Ltd.
Maki Toshio
Pharmaceutical Regulatory Affairs And Quality Assurance Department Pharmaceutical Company Ajinomoto
Nagahama Shinobu
Pharmaceutical Regulatory Affairs And Quality Assurance Department Pharmaceutical Company Ajinomoto
Norimatsu Takeo
Pharmaceutical Regulatory Affairs And Quality Assurance Department Pharmaceutical Company Ajinomoto
Tanaka Shinsuke
Pharmacovigilance Department Mochida Pharmaceutical Co. Ltd.

著作論文

The Effect of Combination Therapy with an L/N-Type Ca^ Channel Blocker Cilnidipine, and an Angiotensin II Receptor Blocker on the Blood Pressure and Heart Rate in Japanese Hypertensive Patients : An Observational Study Conducted in Japan

スポンサーリンク